In his statement regarding passage of Senate Bill 598, BIO President and CEO Jim Greenwood commended California's Assembly and Senate for "overwhelmingly passing legislation that creates a pathway for the substitution of interchangeable biologic medicines." Greenwood also expressed support for this legislation and encouraged Governor Brown to sign this bill. "BIO is pleased," said Greenwood, "that the California Legislature passed this legislation and continues to put patients first."
This story is related to the following:Trade Associations